🟢 20/20 Biolabs is trading 6.11% up in after-hours trading; no confirmed company-specific announcement

20/20 Biolabs is trading 6.11% higher after hours at $0.37, compared with its regular-session close of $0.35; no confirmed company-specific announcement explaining the move was identified.

• The company is scheduled to host an investor webinar on October 7 about an FDA advisory-panel meeting and its OneTest franchise model. This is an upcoming event, not a confirmed catalyst.
• Major U.S. indexes advanced on October 6, potentially providing a supportive market backdrop, though a direct link to the stock’s move is unconfirmed.